The effect of postoperative medical treatment on left ventricular mass regression after aortic valve replacement

Meghana R.K. Helder, Murat Ugur, Joseph E. Bavaria, Vibhu R. Kshettry, Mark A. Groh, Michael R. Petracek, Kent W. Jones, Rakesh M. Suri, Hartzell V. Schaff

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Objective The study objective was to analyze factors associated with left ventricular mass regression in patients undergoing aortic valve replacement with a newer bioprosthesis, the Trifecta valve pericardial bioprosthesis (St Jude Medical Inc, St Paul, Minn). Methods A total of 444 patients underwent aortic valve replacement with the Trifecta bioprosthesis from 2007 to 2009 at 6 US institutions. The clinical and echocardiographic data of 200 of these patients who had left ventricular hypertrophy and follow-up studies 1 year postoperatively were reviewed and compared to analyze factors affecting left ventricular mass regression. Results Mean (standard deviation) age of the 200 study patients was 73 (9) years, 66% were men, and 92% had pure or predominant aortic valve stenosis. Complete left ventricular mass regression was observed in 102 patients (51%) by 1 year postoperatively. In univariate analysis, male sex, implantation of larger valves, larger left ventricular end-diastolic volume, and beta-blocker or calcium-channel blocker treatment at dismissal were significantly associated with complete mass regression. In the multivariate model, odds ratios (95% confidence intervals) indicated that male sex (3.38 [1.39-8.26]) and beta-blocker or calcium-channel blocker treatment at dismissal (3.41 [1.40-8.34]) were associated with increased probability of complete left ventricular mass regression. Patients with higher preoperative systolic blood pressure were less likely to have complete left ventricular mass regression (0.98 [0.97-0.99]). Conclusions Among patients with left ventricular hypertrophy, postoperative treatment with beta-blockers or calcium-channel blockers may enhance mass regression. This highlights the need for close medical follow-up after operation. Labeled valve size was not predictive of left ventricular mass regression.

Original languageEnglish (US)
Pages (from-to)781-786
Number of pages6
JournalJournal of Thoracic and Cardiovascular Surgery
Volume149
Issue number3
DOIs
StatePublished - Mar 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Helder, M. R. K., Ugur, M., Bavaria, J. E., Kshettry, V. R., Groh, M. A., Petracek, M. R., Jones, K. W., Suri, R. M., & Schaff, H. V. (2015). The effect of postoperative medical treatment on left ventricular mass regression after aortic valve replacement. Journal of Thoracic and Cardiovascular Surgery, 149(3), 781-786. https://doi.org/10.1016/j.jtcvs.2014.10.034